✦ LIBER ✦

OC2. Efficacy, pharmacokinetics, and safety of a cathepsin K (Cat K) inhibitor in the suppression of bone resorption in women with breast cancer and established bone 2

✍ Scribed by Christopher Wynne; Anders Bonde Jensen; Steinar Lundgren; Jose Joaquin Caicedo; Maximiliano Ontaneda; Anish Mehta; Sui Yan; Shabana Ather; Weili He; Yang Song; Yuliya Berd; Antonio Lombardi

Book ID: 116395223
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 41 KB
Volume: 34
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2008.03.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Cathepsin K Inhibitor Odanacatib Sup

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

✍ Anders Bonde Jensen; Christopher Wynne; Guillermo Ramirez; Weili He; Yang Song; 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 647 KB

P6. Anti-resorptive and potential anti-i

P6. Anti-resorptive and potential anti-invasion effects of a cathepsin K inhibitor in the treatment of breast cancer-induced bone metastasis

✍ Patrick Leung; Maureen Pickarski; Gregg A. Wesolowski; Le T. Duong 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Four-year results of a phase 2 study of

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

✍ H. Resch; N. Binkley; H. Bone; J. Eisman; D. Hosking; B. Langdahl; M. McClung; I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Four-year Results of a Phase 2 Study of

Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers

✍ Miller, Paul; Binkley, Neil; Eisman, John; Reid, Ian; Lombardi, Antonio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Bone turnover markers and pharmacokineti

Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women

✍ Nagase, Shinichi; Ohyama, Michiyo; Hashimoto, Yoshitaka; Small, Maria; Sharpe, J 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 425 KB

201 POSTER Denosumab safety, pharmacokin

201 POSTER Denosumab safety, pharmacokinetics (PK), and pharmacodynamics (PD) in a phase 1 study of Japanese women with breast cancer-related bone metastasis

✍ H. Minami; K. Kitagawa; K. Yonemori; Y. Fujiwara; H. Fujii; T. Arai; M. Ohkura; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB